Φορτώνει......
Tumor mutational and indel burden: a systematic pan-cancer evaluation as prognostic biomarkers
BACKGROUND: Tumor mutational burden (TMB) has been widely studied as a predictive biomarker of response to immune checkpoint inhibitors (ICIs). Besides, evidence suggests frameshift indels are a highly immunogenic mutational class and thus a potentially superior biomarker. However, the general progn...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Ann Transl Med |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
AME Publishing Company
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6944566/ https://ncbi.nlm.nih.gov/pubmed/31930041 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.10.116 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|